Neoclerodanes as Atypical Opioid Receptor Ligands: 2012 David W. Robertson Award for Excellence in Medicinal Chemistry

The neoclerodane diterpene salvinorin A is the major active component of the hallucinogenic mint plant Salvia divinorum Epling and Játiva (Lamiaceae). Since the finding that salvinorin A exerts its potent psychotropic actions through the activation of opioid receptors, the site of action of morphin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2013-05, Vol.56 (9), p.3435-3443
1. Verfasser: Prisinzano, Thomas E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3443
container_issue 9
container_start_page 3435
container_title Journal of medicinal chemistry
container_volume 56
creator Prisinzano, Thomas E
description The neoclerodane diterpene salvinorin A is the major active component of the hallucinogenic mint plant Salvia divinorum Epling and Játiva (Lamiaceae). Since the finding that salvinorin A exerts its potent psychotropic actions through the activation of opioid receptors, the site of action of morphine and related analogues, there has been much interest in elucidating the underlying mechanisms behind its effects. These effects are particularly remarkable because (1) salvinorin A is the first reported non-nitrogenous opioid receptor agonist and (2) its effects are not mediated through the previously investigated targets of psychotomimetics. This Perspective outlines our research program, illustrating a new direction to the development of tools to further elucidate the biological mechanisms of drug tolerance and dependence. The information gained from these efforts is expected to facilitate the design of novel agents to treat pain, drug abuse, and other central nervous system disorders.
doi_str_mv 10.1021/jm400388u
format Article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_jm400388u</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>e9034156</sourcerecordid><originalsourceid>FETCH-LOGICAL-a64u-748360eb2e65e6d4fc88bd11bebba4fd6efa2fc5bd9036d935a44d740cb7131f3</originalsourceid><addsrcrecordid>eNptz0tLw0AUBeBBFIzVhf8gGxcuoncemUyXpWgVQgul-zCPO5KQZsJMs-i_N1Jx5epsPg7nEPJI4YUCo6_dUQBwpaYrktGSQSEUiGuSATBWMMn4LblLqYMZUcYzQrcYbI8xOD1gynXKV6fz2Frd57uxDa3L92hxPIWY1-2XHly6Jzde9wkffnNBDu9vh_VHUe82n-tVXWgppqISiktAw1CWKJ3wVinjKDVojBbeSfSaeVsatwQu3ZKXWghXCbCmopx6viDPl1obQ0oRfTPG9qjjuaHQ_Fxt_q7O9ulitU1NF6Y4zMP-cd95fVK2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Neoclerodanes as Atypical Opioid Receptor Ligands: 2012 David W. Robertson Award for Excellence in Medicinal Chemistry</title><source>American Chemical Society Journals</source><creator>Prisinzano, Thomas E</creator><creatorcontrib>Prisinzano, Thomas E</creatorcontrib><description>The neoclerodane diterpene salvinorin A is the major active component of the hallucinogenic mint plant Salvia divinorum Epling and Játiva (Lamiaceae). Since the finding that salvinorin A exerts its potent psychotropic actions through the activation of opioid receptors, the site of action of morphine and related analogues, there has been much interest in elucidating the underlying mechanisms behind its effects. These effects are particularly remarkable because (1) salvinorin A is the first reported non-nitrogenous opioid receptor agonist and (2) its effects are not mediated through the previously investigated targets of psychotomimetics. This Perspective outlines our research program, illustrating a new direction to the development of tools to further elucidate the biological mechanisms of drug tolerance and dependence. The information gained from these efforts is expected to facilitate the design of novel agents to treat pain, drug abuse, and other central nervous system disorders.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm400388u</identifier><language>eng</language><publisher>American Chemical Society</publisher><subject>Perspective</subject><ispartof>Journal of medicinal chemistry, 2013-05, Vol.56 (9), p.3435-3443</ispartof><rights>Copyright © 2013 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a64u-748360eb2e65e6d4fc88bd11bebba4fd6efa2fc5bd9036d935a44d740cb7131f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm400388u$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm400388u$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids></links><search><creatorcontrib>Prisinzano, Thomas E</creatorcontrib><title>Neoclerodanes as Atypical Opioid Receptor Ligands: 2012 David W. Robertson Award for Excellence in Medicinal Chemistry</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>The neoclerodane diterpene salvinorin A is the major active component of the hallucinogenic mint plant Salvia divinorum Epling and Játiva (Lamiaceae). Since the finding that salvinorin A exerts its potent psychotropic actions through the activation of opioid receptors, the site of action of morphine and related analogues, there has been much interest in elucidating the underlying mechanisms behind its effects. These effects are particularly remarkable because (1) salvinorin A is the first reported non-nitrogenous opioid receptor agonist and (2) its effects are not mediated through the previously investigated targets of psychotomimetics. This Perspective outlines our research program, illustrating a new direction to the development of tools to further elucidate the biological mechanisms of drug tolerance and dependence. The information gained from these efforts is expected to facilitate the design of novel agents to treat pain, drug abuse, and other central nervous system disorders.</description><subject>Perspective</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNptz0tLw0AUBeBBFIzVhf8gGxcuoncemUyXpWgVQgul-zCPO5KQZsJMs-i_N1Jx5epsPg7nEPJI4YUCo6_dUQBwpaYrktGSQSEUiGuSATBWMMn4LblLqYMZUcYzQrcYbI8xOD1gynXKV6fz2Frd57uxDa3L92hxPIWY1-2XHly6Jzde9wkffnNBDu9vh_VHUe82n-tVXWgppqISiktAw1CWKJ3wVinjKDVojBbeSfSaeVsatwQu3ZKXWghXCbCmopx6viDPl1obQ0oRfTPG9qjjuaHQ_Fxt_q7O9ulitU1NF6Y4zMP-cd95fVK2</recordid><startdate>20130509</startdate><enddate>20130509</enddate><creator>Prisinzano, Thomas E</creator><general>American Chemical Society</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20130509</creationdate><title>Neoclerodanes as Atypical Opioid Receptor Ligands</title><author>Prisinzano, Thomas E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a64u-748360eb2e65e6d4fc88bd11bebba4fd6efa2fc5bd9036d935a44d740cb7131f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Perspective</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prisinzano, Thomas E</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prisinzano, Thomas E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neoclerodanes as Atypical Opioid Receptor Ligands: 2012 David W. Robertson Award for Excellence in Medicinal Chemistry</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2013-05-09</date><risdate>2013</risdate><volume>56</volume><issue>9</issue><spage>3435</spage><epage>3443</epage><pages>3435-3443</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>The neoclerodane diterpene salvinorin A is the major active component of the hallucinogenic mint plant Salvia divinorum Epling and Játiva (Lamiaceae). Since the finding that salvinorin A exerts its potent psychotropic actions through the activation of opioid receptors, the site of action of morphine and related analogues, there has been much interest in elucidating the underlying mechanisms behind its effects. These effects are particularly remarkable because (1) salvinorin A is the first reported non-nitrogenous opioid receptor agonist and (2) its effects are not mediated through the previously investigated targets of psychotomimetics. This Perspective outlines our research program, illustrating a new direction to the development of tools to further elucidate the biological mechanisms of drug tolerance and dependence. The information gained from these efforts is expected to facilitate the design of novel agents to treat pain, drug abuse, and other central nervous system disorders.</abstract><pub>American Chemical Society</pub><doi>10.1021/jm400388u</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2013-05, Vol.56 (9), p.3435-3443
issn 0022-2623
1520-4804
language eng
recordid cdi_crossref_primary_10_1021_jm400388u
source American Chemical Society Journals
subjects Perspective
title Neoclerodanes as Atypical Opioid Receptor Ligands: 2012 David W. Robertson Award for Excellence in Medicinal Chemistry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T02%3A41%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neoclerodanes%20as%20Atypical%20Opioid%20Receptor%20Ligands:%202012%20David%20W.%20Robertson%20Award%20for%20Excellence%20in%20Medicinal%20Chemistry&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Prisinzano,%20Thomas%20E&rft.date=2013-05-09&rft.volume=56&rft.issue=9&rft.spage=3435&rft.epage=3443&rft.pages=3435-3443&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm400388u&rft_dat=%3Cacs_cross%3Ee9034156%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true